help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arimura, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arimura, A.
Endocrinology Vol. 143, No. 10 3715-3716
Copyright © 2002 by The Endocrine Society


ARTICLE

Editorial: Impaired Adaptive Thermogenesis in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice

Akira Arimura

U.S.-Japan Biomedical Research Laboratories, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112

Address all correspondence and requests for reprints to: Akira Arimura, M.D., Ph.D., U.S.-Japan Biomedical Research Laboratory, Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, Box SL-21, New Orleans, Louisiana 70112. E-mail: Arimura{at}tulane.edu.


    Introduction
 Top
 Introduction
 References
 
Pituitary adenylate cyclase-activating polypeptide (PACAP) belongs to the glucagon/secretin/vasoactive intestinal peptide (VIP)/GHRH family of peptides and has various biological actions. PACAP is most abundant in the central nervous system, but it also exists in the peripheral nervous system. In the nervous system, PACAP functions as a neurotransmitter, neuromodulator, and neurotrophic factor (1). Among its family of peptides, PACAP is the most highly conserved peptide during evolution, as indicated by the fact that its primary structures in all of the various mammals so-far examined are identical, and that the peptide in even a nonvertebrate marine chordate, the tunicate, has a highly similar amino acid sequence to that of human PACAP (2). Considering the evolution from tunicate to man, the structure of PACAP may have been conserved during 700 million years of evolution (2). This implies that the peptide has played a vital role in the adaptation of the living organisms to the ever-changing environmental conditions.

Three laboratories (3, 4, 5) have prepared PACAP knockout mice, and two groups have reported a high mortality during early ages. The Sherwood group (3) previously reported that most of the homozygous PACAP null mice died within the first 2 wk after birth in a wasted state with lipid droplets in the liver, heart, and skeletal muscle cells. The same group reported in this issue of Endocrinology (6) that the premature death of the PACAP-deficient mice that occurred when the animals were raised at 21 C resulted from impaired adaptive thermogenesis. When these animals were raised at an environmental temperature of 21 C, only 11% of the PACAP-deficient mice survived past the first 2 wk. The premature death of PACAP null mice was prevented when these animals were raised at an environmental temperature of 24 C. At this temperature, 76% of the PACAP-deficient mice survived. Furthermore, when the 7-d-old mice were separated from the mother and placed at 21 C, the PACAP null mice showed a greater loss of core body temperature compared with the wild-type mice, indicating an impaired thermal adaptation in the PACAP-deficient animals.

Thermogenesis in response to cold stress takes place by two different mechanisms: adaptive thermogenesis that occurs in the brown adipose tissues and shivering thermogenesis in the skeletal muscles. In the neonate and small rodents, adaptive thermogenesis that takes place in the brown adipose tissues plays a major role in the production of heat in a cold environment. On the other hand, in large animals including adult humans, shivering thermogenesis is the major mechanism of heat production. Adaptive thermogenesis is mediated by norepinephrine, which is released from the sympathetic nerve endings distributed in the brown adipocytes and the blood vessels in the brown adipose tissues (7). The importance of norepinephrine and epinephrine in thermogenesis is supported by the finding that mice deficient in dopamine ß-hydroxylase, the enzyme that catalyzes the conversion of dopamine to norepinephrine, are highly cold sensitive (8). In the brown adipose tissue, norepinephrine released by the nerve endings binds to the ß-adrenergic receptors of brown adipocytes and activates hormone-sensitive (HS) lipase and uncoupling protein 1 (UCP1). Activated HS lipase catalyzes the breakdown of stored triglycerides into free fatty acids, which then enter the mitochondria. UCP1 is the only protein that can uncouple respiration from ATP formation and release energy in the form of heat. UCP1-deficient animals are also intolerant to the cold (9).

Gray et al. (6) observed that the levels of norepinephrine and its precursor, dopamine, in the brown adipose tissues of the PACAP null mice were significantly lower than those in the control mice. Neither the mass nor the histology of the interscapular brown adipose tissues of PACAP-deficient mice differed from those in the wild-type mice. On the other hand, the levels of the mRNAs for both HS lipase and UCP1 in the brown adipose tissues were increased by 1.6-fold. Although tyrosine hydroxylase (TH) mRNA levels in the brown adipose tissues were not reported, the levels of TH mRNA in the adrenal medulla of the PACAP null mice were two times greater than those in the heterozygous and wild-type controls. On the other hand, the levels of epinephrine and norepinephrine in the adrenal medulla in PACAP-deficient mice did not differ from those in the heterozygous and wild-type mice. The increased levels of TH mRNA in the adrenal medulla could reflect a compensatory response designed to restore the lowered levels of catecholamines in these tissues. Neither norepinephrine nor epinephrine levels in the plasma differed among the three genotypes. On the other hand, dopamine levels in the plasma of PACAP null mice and heterozygous mice were lower than those in the wild-type mice. Although the reason for the lowered plasma dopamine level was not reported in this study, it is possible that TH activity in the tissues or organs that are a major source for circulating dopamine, including the stomach (10), could be altered in PACAP null mice. Although PACAP may stimulate the expression of TH, dopamine ß-hydroxylase, and phenylethanolamine-N-methyltransferase (11), the peptide may not necessarily play an obligatory role in the transcription of their mRNAs. In the adrenal medulla of PACAP-deficient mice, the TH mRNA levels were increased compared with those in the control mice. More importantly, PACAP may play a critical role in activation (phosphorylation) of TH (12). Unfortunately, the present paper does not report the levels of phosphorylated TH in the brown adipose tissues and adrenal medulla of PACAP null mice, the amount of TH activity, or, more important, the turnover rate of norepinephrine in brown adipose tissues.

PACAP binds to not only the PACAP-specific receptor, PAC1 receptor, but also to two types of VIP receptors, called VPAC1 receptors and VPAC2 receptors, with the same or even a higher affinity than VIP (1). On the other hand, VIP binds to PAC1 receptors with an affinity 1000 times lower than PACAP. The impaired adaptive thermogenesis in the PACAP null mice, in which the expression of VIP may be unaffected, suggests that the effect of PACAP is not mediated by VPAC1 receptors or VPAC2 receptors, but by PAC1 receptors. The premature death of PAC1-receptor-deficient mice has also been observed. The rate of premature death of the PAC1-receptor-deficient mice is approximately 50–70% before weaning. Although the mortality rate of the wild-type mice of the same strain, C57BL/6, is already high, PAC1-receptor-deficient mice died twice as frequently as the wild-type and heterozygous mice before weaning. These animals were raised at a room temperature of 20–22 C, an average of 21 C (Brabet, P., personal communication). The paper by Gray et al. in this issue (6) shows that at this temperature, only 11% of the PACAP null mice survived after weaning. PACAP null mice prepared by Baba’s group (4) also showed a greater mortality within a few days after genotyping with tail cutting on d 0. The mortality rates of the wild-type, heterozygous, and homozygous animals, all of which were subjected to genotyping on d 0, were 31.7%, 25.3%, and 72.2%, respectively. Among the animals that survived after genotyping, premature death within 3–4 wk was noted only in PACAP null mice. These animals were raised at around 23 C (Baba, A., personal communication). Whether the premature death of these animals resulted from impaired adaptive thermogenesis at the relatively low temperature in the animal quarters is unknown. However, the findings suggest that PACAP null mice are also intolerant to various adverse stresses such as tail cutting for genotyping. Although the levels of catecholamines in the adrenal medulla of the PACAP null mice do not differ from the levels in the control mice, these animals showed an increased mortality after an insulin challenge due to prolonged hypoglycemia resulting from an inability to maintain sustained epinephrine release from the adrenal medulla (5). On the other hand, the administration of PACAP attenuated septic shock in mice (13) and dogs (14). PACAP also showed a significant antiinflammatory response (15).

Gray et al. (3) previously reported that PACAP null mice died in a wasted state with lipid droplets in the liver, heart, and skeletal muscles. The authors now report that the PACAP null mice raised at 24 C no longer showed the wasted state (6). However, it was not reported whether lipid deposition in the liver, heart, and skeletal muscles is still present in the PACAP null mice raised at 24 C. It is an interesting issue whether the impaired adaptive thermogenesis and abnormal lipid metabolism in the PACAP null mice are independent consequences of the absence of PACAP.

In conclusion, the report by Gray et al. in this issue (6) provides important information about the physiological role of PACAP in the adaptation of the living body to a cold environment, through adaptive thermogenesis by the brown adipose tissues. The adaptive action to the low temperature and the protective action of PACAP to other stresses appear to be mediated by its stimulatory action to sustain the production of catecholamines in the sympathetic nerves and the adrenal medulla. These findings suggest the vital role of this peptide in the protection of the living body from adverse influences and in adapting to the ever changing external environment. The vital role of PACAP in adaptation could be consistent with the highly conserved structure of PACAP during the evolution.


    Acknowledgments
 
I thank Dr. Philippe Brabet and Dr. Akemichi Baba for discussions about the PAC1-receptor and PACAP null mice and their permission to use their information in this editorial. I also thank Dr. Jerome L. Maderdrut for his editorial help.


    Footnotes
 
Abbreviations: HS, Hormone-senstive; PACAP, pituitary adenylate cyclase-activating polypeptide; TH, tyrosine hydroxylase; UCP1, uncoupling protein 1; VIP, vasoactive intestinal peptide.

Received August 1, 2002.

Accepted for publication August 1, 2002.


    References
 Top
 Introduction
 References
 

  1. Arimura A 1998 Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48:301–331[CrossRef][Medline]
  2. Sherwood NM, Krueckl SL, McRory JE 2000 The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 21:619–670[Abstract/Free Full Text]
  3. Gray SL, Cummings KJ, Jirik FR, Sherwood NM 2001 Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol Endocrinol 15:1739–1747[Abstract/Free Full Text]
  4. Hashimoto H, Shintani N, Tanaka K, Mori W, Hirose M, Matsuda T, Sakaue M, Miyazaki J, Niwa H, Tashiro F, Yamamoto K, Koga K, Tomimoto S, Kunugi A, Suetake S, Baba A 2001 Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci USA 98:13355–13360[Abstract/Free Full Text]
  5. Hamelink C, Tjurmina O, Damadzic R, Young WS, Weihe E, Lee HW, Eiden LE 2002 Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Proc Natl Acad Sci USA 99:461–466[Abstract/Free Full Text]
  6. Gray SL, Yamaguchi N, Vencová P, Sherwood NM 2002 Temperature- sensitive phenotype in mice lacking pituitary adenylate cyclase-activating polypeptide. Endocrinology 143:3946–3954[Abstract/Free Full Text]
  7. Ricquier D, Miroux B, Larose M, Cassard-Doulcier AM, Bouillaud F 2000 Endocrine regulation of uncoupling proteins and energy expenditure. Int J Obes Relat Metab Disord 24(Suppl 2):S86–S88
  8. Thomas SA, Palmiter RD 1997 Thermoregulatory and metabolic phenotypes of mice lacking noradrenaline and adrenaline. Nature 387:94–97[CrossRef][Medline]
  9. Nedergaard J, Golozoubova V, Matthias A, Asadi A, Jacobsson A, Cannon B 2001 UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. Biochim Biophys Acta 1504:82–106[Medline]
  10. Kozicz T, Arimura A 2002 Distribution of urocortin in the rat’s gastrointestinal tract and its colocalization with tyrosine hydroxylase. Peptides 23:515–521[CrossRef][Medline]
  11. Tonshoff C, Hemmick L, Evinger MJ 1997 Pituitary adenylate cyclase activating polypeptide (PACAP) regulates expression of catecholamine biosynthetic enzyme genes in bovine adrenal chromaffin cells. J Mol Neurosci 9:127–140[Medline]
  12. Haycock JW 1996 Short- and long-term regulation of tyrosine hydroxylase in chromaffin cells by VIP and PACAP. Ann NY Acad Sci 805:219–230; discussion 230–231[Medline]
  13. Martinez C, Abad C, Delgado M, Arranz A, Juarranz MG, Rodriguez-Henche N, Brabet P, Leceta J, Gomariz RP 2002 Anti-inflammatory role in septic shock of pituitary adenylate cyclase- activating polypeptide receptor. Proc Natl Acad Sci USA 99:1053–1058[Abstract/Free Full Text]
  14. Suzuki Y, Kasai K, Iino I, Takekoshi K, Oka M, Shimoda S 1994 Anti-shock effect of pituitary adenylate cyclase activating polypeptide (PACAP) on experimental endotoxin shock in dogs. Life Sci 54:PL389–PL394
  15. Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D 1999 Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. J Immunol 162:1707–1716[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. J. Cummings, C. Willie, and R. J. A. Wilson
Pituitary adenylate cyclase-activating polypeptide maintains neonatal breathing but not metabolism during mild reductions in ambient temperature
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R956 - R965.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arimura, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arimura, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals